Item 2.02. Results of Operations and Financial Condition.
On March 2, 2020, Neon Therapeutics, Inc. (the "Company") issued a press release
announcing its financial results for the quarter and year ended December 31,
2019. A copy of the press release is being furnished as Exhibit 99.1 to this
Current Report on Form 8-K.
The information contained in this Current Report on Form 8-K and Exhibit 99.1
attached hereto is intended to be furnished and shall not be deemed "filed" for
purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange
Act") or otherwise subject to the liabilities of that section, nor shall it be
deemed incorporated by reference in any filing under the Securities Act of 1933
or the Exchange Act, except as expressly set forth by specific reference in such
a filing.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
Exhibit No.                                Description
99.1             Press release issued by the Company on March 2, 2020, furnished
               herewith



                                       2

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses